CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Turkey

1
CountryFocus Healthcare, Regulatory and
Reimbursement Landscape - Turkey
One-Stop Shop for Business Information
2
Summary
CountryFocus Healthcare, Regulatory and
Reimbursement Landscape - Turkey. The report is
an essential source of information on and
analysis of the healthcare, regulatory and
reimbursement landscape in Turkey. It identifies
the key trends in the countrys healthcare market
and provides insights into its demographic,
regulatory, and reimbursement landscape and
healthcare infrastructure. Most importantly, the
report provides valuable insights into the trends
and segmentation of its pharmaceutical and
medical device markets. It uses data and
information sourced from proprietary databases,
secondary research, and in-house analysis by
GlobalDatas team of industry experts.
3
Turkeys population stood at approximately 76.7
million in 2013, having grown at a Compound
Annual Growth Rate (CAGR) of 1.4, from 2008. The
implementation of the Health Transformation
Program (Saglikta Donus, um Programi, HTP)
resulted in social security reforms that were
aimed at improving the universal health coverage.
The available infrastructure for healthcare
industries and the high number of healthcare
institutions makes Turkey an attractive location
for the manufacture and marketing of
pharmaceutical products.
4
The government is trying to increase
pharmaceutical RD in Turkey, and in 2012, it
introduced a new investment incentives program
that had four basic schemes to increase foreign
investment. The pharmaceutical market was worth
approximately 12.5 billion, in 2012, and was the
sixth-largest pharmaceutical market in Europe. It
is set to grow at a CAGR of 7.3 from 2008 to
reach 21.5 billion in 2020. The medical device
market was valued at approximately 1.9 billion
in 2008 and is estimated to grow at a CAGR of
4.7 to reach an estimated 3.3 billion in 2020.
These positive growth trends can be primarily
attributed to - An increasing elderly
population - Universal health coverage -
Government initiatives
5
ScopeThe report provides information on the
healthcare, regulatory, and reimbursement
landscape in Turkey, and includes - - An
overview of the pharmaceutical and medical device
markets, comprising market size, segmentation,
and key drivers and barriers- Profiles and SWOT
analyses of the major players in the
pharmaceutical market Abdi Ibrahim, Novartis,
Sanofi, Bilim and Pfizer and profiles and SWOT
analyses of the major players in the medical
device market Siemens Healthcare, F. Hoffmann-La
Roche, Essilor International, GE healthcare, and
Fresenius Medical Care
6
- Insightful review of the reimbursement and
regulatory landscape, with analysis covering
details of the countrys healthcare reimbursement
process, regulatory agencies and the approval
processes for new drugs and medical devices-
Detailed analysis of the political and economic
environment, covering economic indicators,
demographics, healthcare infrastructure and
healthcare expenditure- An overview of the
opportunities for and challenges to growth in the
healthcare market
7
Table Of Content

1. Table of Contents
2. Introduction
3. GlobalData Report Guidance
4. Overview of the Pharmaceutical and Medical Device
   Markets
5. Market Access
6. Country Analysis
7. Opportunities and Challenges
8. Appendix

8

• For more info CountryFocus Healthcare,
  Regulatory and Reimbursement Landscape -
  Turkey
• For Discounted Reports Kindly Click Here

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email id
info_at_bharatbook.com